Modular rGlyP engineering and NADPH balancing enable aerobic growth on formate, methanol, methane, or CO2 for sustainable bioproduction.
Engineered microorganisms convert methane into multi-carbon fuels and chemicals, cutting reliance on petroleum and food-based feedstocks.
Site-specific PEGylation helps phenylalanine lyase retain activity, lower immunogenicity, and sustain plasma exposure for PKU treatment.
Engineered bacteria use an enzymatic biosynthetic pathway to make enantiopure L-piperazic acid at lower cost and with fewer synthetic steps.
Targeted PAL amino acid substitutions improve catalytic activity, thermal stability, and aggregation resistance for more durable PKU therapy.